IVI Research Brief Uses Insurance Value to Determine Long-Term Value of Therapies

July 29, 2019

A research brief from the Innovation and Value Initiative (IVI) looked at how the concept of insurance value can help stakeholders understand the value of therapies to the broader population.

A research brief from the Innovation and Value Initiative (IVI) looked at how the concept of insurance value can help stakeholders understand the value of therapies to the broader population. Insurance value measures the value that medical technologies offer healthy individuals by reducing the physical risks of possible illness, and the concept has been suggested as one of several elements to improve and enhance conventional cost-effecteness analysis.

The brief used IVI's Open-Source Value Platform mofel for rheumatoid arthritis (RA) to explore the application of insurance value because treatent of RA focuses on reducing impacts on quality of life rather than addressing mortality concerns.